Mental Health, Addictions and Biomarkers in High Athletes Performance

February 6, 2023 updated by: Isabel Almodóvar Fernández, Cardenal Herrera University

Presence of Psychopathy and Antisocial Personality Disorder as Well as Genetic Biomarkers and the Inhibition-prepulse Endophenotype in Elite Athletes

Sport is a privileged area to promote socialization and health values, such as companionship; a healthy lifestyle; cooperation to achieve common goals, and justice, rejecting unjustified advantages in competition. The concept of fair play is on which the development of those values pivots. From a holistic perspective, it is possible to define fair play, not only as a way to participate but also as a way of projecting people in life with values, assuming a set of behaviors that enhance a healthy and respectful sporting experience with opponents, the companions, the spectators, the referees and all the agents that take part in the sport practice.

Study Overview

Detailed Description

Sport is a privileged area to promote socialization and health values, such as companionship; a healthy lifestyle; cooperation to achieve common goals, and justice, rejecting unjustified advantages in competition. The concept of fair play is on which the development of those values pivots. From a holistic perspective, it is possible to define fair play, not only as a way to participate but also as a way of projecting people in life with values, assuming a set of behaviors that enhance a healthy and respectful sporting experience with opponents, the companions, the spectators, the referees and all the agents that take part in the sport practice.

Since 2018, joint actions have been carried out with the Villarreal de Fútbol Club, within the framework of the ENDAVANT agreement. Within these actions, it is proposed to develop different lines of research on sport and health. Within these lines, one of special relevance is that related to the risk of consumption of illicit substances and / or behavioral addictions, in elite athletes, since they are subjected to intense training days and stress situations derived from the demands of performance of professional competitive activity. On the other hand, recently published behavioral studies show that athletes who practice non-contact sports have a greater capacity to identify and assess emotions than athletes who practice contact sports and than those who practice contact sports show higher levels of physical aggression or verbal, and hostility or anger, than athletes who practice individual and non-contact sports.

Study Type

Observational

Enrollment (Actual)

306

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Castellón
      • Villa-Real, Castellón, Spain, 12540
        • Villarreal CF
      • Villarreal, Castellón, Spain, 12540
        • Villarreal CF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elite football players from Spanish football league

Description

Inclusion Criteria:

  • active athletes in the elite soccer competition from the Villarreal CF, who agree to be included in the study by signing an informed consent and who have a health profile made by the club's Medical Service.

Exclusion Criteria:

  • athletes who are transferred to other clubs during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Common drugs
Time Frame: 2 years
Describe the consumption of common drugs in elite athletes.
2 years
Identify other mental disorders
Time Frame: 2 years
Identify other mental disorders differents than addictions and psychopathy in elite athletes.
2 years
Explore the consumption of new psychoactive substances
Time Frame: 2 years
Explore the consumption of new psychoactive substances in elite athletes
2 years
Pathological gambling
Time Frame: 2 years
Describe the study of behavioral addictions and video game addiction in elite athletes.
2 years
Mental disorders
Time Frame: 2 years
Describe the presence of psychopathy and antisocial personality disorder
2 years
Genetic biomarkers
Time Frame: 2 years
Describe genetic biomarkers endophenotype in elite athletes.
2 years
Dopping
Time Frame: 2 years
Describe new dopping substances in elite atheletes.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 15, 2020

Primary Completion (ACTUAL)

March 10, 2021

Study Completion (ACTUAL)

July 31, 2022

Study Registration Dates

First Submitted

April 7, 2021

First Submitted That Met QC Criteria

April 9, 2021

First Posted (ACTUAL)

April 13, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

3
Subscribe